You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Hydrochlorothiazide; olmesartan medoxomil - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for hydrochlorothiazide; olmesartan medoxomil and what is the scope of freedom to operate?

Hydrochlorothiazide; olmesartan medoxomil is the generic ingredient in three branded drugs marketed by Cosette, Alkem Labs Ltd, Accord Hlthcare, Alembic, Aurobindo Pharma, Macleods Pharms Ltd, Natco Pharma Usa, Prinston Inc, Teva Pharms Usa, Torrent, Umedica, and Zydus Pharms, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

Twelve suppliers are listed for this compound.

Recent Clinical Trials for hydrochlorothiazide; olmesartan medoxomil

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Altasciences Company, Inc.Phase 1
Altasciences Company Inc.Phase 1
Pharmtechnology LLCPhase 1

See all hydrochlorothiazide; olmesartan medoxomil clinical trials

Pharmacology for hydrochlorothiazide; olmesartan medoxomil
Paragraph IV (Patent) Challenges for HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
BENICAR HCT Tablets hydrochlorothiazide; olmesartan medoxomil 20 mg/12.5 mg 021532 1 2007-05-11
BENICAR HCT Tablets hydrochlorothiazide; olmesartan medoxomil 40 mg/12.5 mg and 40 mg/25 mg 021532 1 2007-02-15

US Patents and Regulatory Information for hydrochlorothiazide; olmesartan medoxomil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prinston Inc OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 207804-003 Apr 24, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 205391-001 Apr 24, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 205391-002 Apr 24, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Accord Hlthcare OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 209281-001 Feb 7, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 206377-003 Feb 24, 2023 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for hydrochlorothiazide; olmesartan medoxomil

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.